Serum circFUT8 in gastric cancer: Diagnostic performance and clinicopathological associations

Gastric cancer (GC) remains a major cause of cancer-related morbidity and mortality, and biomarkers that complement current diagnostic approaches are needed. Circular RNAs (circRNAs) are promising biomarker candidates because of their stability. We characterized circFUT8 and evaluated its potential as an auxiliary serum biomarker for GC. Its circular structure and stability were assessed by back-splice junction validation, freeze-thaw and room-temperature stability assays, actinomycin D treatment, and ribonuclease R (RNase R) digestion. Real-time quantitative PCR (RT-qPCR) was used to measure circFUT8 expression in 45 pairs of GC and adjacent non-tumor tissues and in serum from 102 patients with GC, 32 patients with gastritis, and 78 healthy controls. CircFUT8 was generated by back-splicing of exons 3-6 of FUT8 and showed a distinct back-splice junction, stability under the tested conditions, and resistance to RNase R digestion. CircFUT8 expression was increased in GC tissues and serum. Serum circFUT8 distinguished GC from healthy controls, gastritis, and pooled non-GC controls, with areas under the receiver operating characteristic curve (AUCs) of 0.725, 0.756, and 0.734, respectively. Combining circFUT8 with carcinoembryonic antigen (CEA) and CA19-9 yielded the highest apparent AUC of 0.765 against healthy controls (optimism-corrected AUC, 0.756). However, the combined models did not significantly outperform circFUT8 alone. Higher serum circFUT8 levels, analyzed as a continuous variable, were associated with poorly differentiated or undifferentiated histology, lymph node metastasis, higher T stages, and advanced tumor-node-metastasis (TNM) stages. CircFUT8 also showed modest discriminatory performance for T1 and TNM stage I-II disease in exploratory analyses. These findings support serum circFUT8 as a candidate auxiliary biomarker for GC, pending validation in larger, independent cohorts.

Authors

Institutions

Publication Details

Journal
Biomolecules and Biomedicine
Published
2026-11-12
DOI
https://doi.org/10.17305/bb.2026.14950
Primary Topic
Circular RNAs in diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Serum circFUT8 in gastric cancer: Diagnostic performance and clinicopathological associations

Shiyi Qin, Ruoyu Yuan, 鞠少卿, Ming Zheng et al.
Biomolecules and Biomedicine
Circular RNAs in diseases
article

Serum circFUT8 in gastric cancer: Diagnostic performance and clinicopathological associations

Shiyi Qin, Ruoyu Yuan, 鞠少卿, Ming Zheng, Xinyue Qin, Weiwei Zhang, Mei Tao
article en

Abstract

Gastric cancer (GC) remains a major cause of cancer-related morbidity and mortality, and biomarkers that complement current diagnostic approaches are needed. Circular RNAs (circRNAs) are promising biomarker candidates because of their stability. We characterized circFUT8 and evaluated its potential as an auxiliary serum biomarker for GC. Its circular structure and stability were assessed by back-splice junction validation, freeze-thaw and room-temperature stability assays, actinomycin D treatment, and ribonuclease R (RNase R) digestion. Real-time quantitative PCR (RT-qPCR) was used to measure circFUT8 expression in 45 pairs of GC and adjacent non-tumor tissues and in serum from 102 patients with GC, 32 patients with gastritis, and 78 healthy controls. CircFUT8 was generated by back-splicing of exons 3-6 of FUT8 and showed a distinct back-splice junction, stability under the tested conditions, and resistance to RNase R digestion. CircFUT8 expression was increased in GC tissues and serum. Serum circFUT8 distinguished GC from healthy controls, gastritis, and pooled non-GC controls, with areas under the receiver operating characteristic curve (AUCs) of 0.725, 0.756, and 0.734, respectively. Combining circFUT8 with carcinoembryonic antigen (CEA) and CA19-9 yielded the highest apparent AUC of 0.765 against healthy controls (optimism-corrected AUC, 0.756). However, the combined models did not significantly outperform circFUT8 alone. Higher serum circFUT8 levels, analyzed as a continuous variable, were associated with poorly differentiated or undifferentiated histology, lymph node metastasis, higher T stages, and advanced tumor-node-metastasis (TNM) stages. CircFUT8 also showed modest discriminatory performance for T1 and TNM stage I-II disease in exploratory analyses. These findings support serum circFUT8 as a candidate auxiliary biomarker for GC, pending validation in larger, independent cohorts.

Biomolecules and Biomedicine
Nantong University (CN), Affiliated Hospital of Nantong University (CN), First People's Hospital of Kunshan (CN)
National Natural Science Foundation of China, Government of Jiangsu Province, Science and Technology Support Program of Jiangsu Province
Good health and well-being
Circular RNAs in diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon